國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Biopharmaceutical applied statistics...

Chen, Ding-Geng.

Biopharmaceutical applied statistics symposium.Volume 2,Biostatistical analysis of clinical trials

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Biopharmaceutical applied statistics symposium.edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon.
其他作者:	Peace, Karl E.
出版者:	Singapore :Springer Singapore :2018.
面頁冊數:	xiii, 245 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	DrugsTesting
電子資源:	https://doi.org/10.1007/978-981-10-7826-2
ISBN:	9789811078262$q(electronic bk.)

Biopharmaceutical applied statistics symposium.Volume 2,Biostatistical analysis of clinical trials
Biopharmaceutical applied statistics symposium.Volume 2,Biostatistical analysis of clinical trials[electronic resource] /edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon. - Singapore :Springer Singapore :2018. - xiii, 245 p. :ill., digital ;24 cm. - ICSA book series in statistics,2199-0980. - ICSA book series in statistics..

On Statistical Approaches to Meta-analysis of Randomized Clinical Trials -- Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies -- Generalized Tests in Clinical Trials -- Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free -- Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia -- Some Statistical Issues in Patient-reported Outcomes -- Network Meta-analysis -- Detecting Safety Signals Among Adverse Events in Clinical Trials -- Applied Meta-analysis using R -- Treatment of Missing Data in Comparative Effectiveness Research -- Missing Data -- Bayesian Subgroup Analysis with Examples -- Statistical Methods in Diagnostic Devices -- A Question-Based Approach to the Analysis of Safety Data -- Analysis of Two-stage Adaptive Seamless Trial Design -- Multiplicity Problems in Clinical Trials - A Regulatory Perspective.

This BASS book Series publishes selected high-quality papers reflecting recent advances in the design and biostatistical analysis of biopharmaceutical experiments - particularly biopharmaceutical clinical trials. The papers were selected from invited presentations at the Biopharmaceutical Applied Statistics Symposium (BASS), which was founded by the first Editor in 1994 and has since become the premier international conference in biopharmaceutical statistics. The primary aims of the BASS are: 1) to raise funding to support graduate students in biostatistics programs, and 2) to provide an opportunity for professionals engaged in pharmaceutical drug research and development to share insights into solving the problems they encounter. The BASS book series is initially divided into three volumes addressing: 1) Design of Clinical Trials; 2) Biostatistical Analysis of Clinical Trials; and 3) Pharmaceutical Applications. This book is the second of the 3-volume book series. The topics covered include: Statistical Approaches to the Meta-analysis of Randomized Clinical Trials, Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies, Generalized Tests in Clinical Trials, Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free , Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia, Selected Statistical Issues in Patient-reported Outcomes, Network Meta-analysis, Detecting Safety Signals Among Adverse Events in Clinical Trials, Applied Meta-analysis Using R, Treatment of Missing Data in Comparative Effectiveness Research, Causal Estimands: A Common Language for Missing Data, Bayesian Subgroup Analysis with Examples, Statistical Methods in Diagnostic Devices, A Question-Based Approach to the Analysis of Safety Data, Analysis of Two-stage Adaptive Seamless Trial Design, and Multiplicity Problems in Clinical Trials - A Regulatory Perspective.

ISBN: 9789811078262$q(electronic bk.)

Standard No.: 10.1007/978-981-10-7826-2doiSubjects--Topical Terms:

217216
Drugs
--Testing

LC Class. No.: RS189 / .B567 2018

Dewey Class. No.: 617.040287

Biopharmaceutical applied statistics symposium.Volume 2,Biostatistical analysis of clinical trials
LDR:04182nmm a2200349 a 4500 001 543975
003 DE-He213
005 20190304134302.0
006 m d
007 cr nn 008maaau
008 190430s2018 si s 0 eng d
020 $a 9789811078262$q(electronic bk.)
020 $a 9789811078255$q(paper)
024 7 $a 10.1007/978-981-10-7826-2 $2 doi
035 $a 978-981-10-7826-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RS189 $b .B567 2018
072 7 $a PBT $2 bicssc
072 7 $a MED090000 $2 bisacsh
072 7 $a PBT $2 thema
072 7 $a MBNS $2 thema
082 0 4 $a 617.040287 $2 23
090 $a RS189 $b .B615 2018
245 0 0 $a Biopharmaceutical applied statistics symposium. $n Volume 2, $p Biostatistical analysis of clinical trials $h [electronic resource] / $c edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a xiii, 245 p. : $b ill., digital ; $c 24 cm.
490 1 $a ICSA book series in statistics, $x 2199-0980
505 0 $a On Statistical Approaches to Meta-analysis of Randomized Clinical Trials -- Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies -- Generalized Tests in Clinical Trials -- Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free -- Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia -- Some Statistical Issues in Patient-reported Outcomes -- Network Meta-analysis -- Detecting Safety Signals Among Adverse Events in Clinical Trials -- Applied Meta-analysis using R -- Treatment of Missing Data in Comparative Effectiveness Research -- Missing Data -- Bayesian Subgroup Analysis with Examples -- Statistical Methods in Diagnostic Devices -- A Question-Based Approach to the Analysis of Safety Data -- Analysis of Two-stage Adaptive Seamless Trial Design -- Multiplicity Problems in Clinical Trials - A Regulatory Perspective.
520 $a This BASS book Series publishes selected high-quality papers reflecting recent advances in the design and biostatistical analysis of biopharmaceutical experiments - particularly biopharmaceutical clinical trials. The papers were selected from invited presentations at the Biopharmaceutical Applied Statistics Symposium (BASS), which was founded by the first Editor in 1994 and has since become the premier international conference in biopharmaceutical statistics. The primary aims of the BASS are: 1) to raise funding to support graduate students in biostatistics programs, and 2) to provide an opportunity for professionals engaged in pharmaceutical drug research and development to share insights into solving the problems they encounter. The BASS book series is initially divided into three volumes addressing: 1) Design of Clinical Trials; 2) Biostatistical Analysis of Clinical Trials; and 3) Pharmaceutical Applications. This book is the second of the 3-volume book series. The topics covered include: Statistical Approaches to the Meta-analysis of Randomized Clinical Trials, Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies, Generalized Tests in Clinical Trials, Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free , Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia, Selected Statistical Issues in Patient-reported Outcomes, Network Meta-analysis, Detecting Safety Signals Among Adverse Events in Clinical Trials, Applied Meta-analysis Using R, Treatment of Missing Data in Comparative Effectiveness Research, Causal Estimands: A Common Language for Missing Data, Bayesian Subgroup Analysis with Examples, Statistical Methods in Diagnostic Devices, A Question-Based Approach to the Analysis of Safety Data, Analysis of Two-stage Adaptive Seamless Trial Design, and Multiplicity Problems in Clinical Trials - A Regulatory Perspective.
650 0 $a Drugs $x Testing $x Statistical methods $3 217216
650 0 $a Biopharmaceutics $v Congresses. $3 822414
650 1 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 274067
650 2 4 $a Biostatistics. $3 339693
700 1 $a Peace, Karl E. $3 776794
700 1 $a Chen, Ding-Geng. $3 487343
700 1 $a Menon, Sandeep. $3 822413
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a ICSA book series in statistics. $3 725077
856 4 0 $u https://doi.org/10.1007/978-981-10-7826-2
950 $a Mathematics and Statistics (Springer-11649)